CHEK1 and colorectal carcinoma: Altogether, these findings demonstrate that prolonged impairment of the RSR by CHK1i results in increased resistance of CRC-SCs to clinically-relevant replication poisons and to inhibitors of the ATR-CHK1 cascade.